嘉事堂(002462) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 was ¥6,789,118,230.69, representing a year-on-year increase of 3.23%[3] - The net profit attributable to shareholders for Q3 2021 was ¥90,449,294.09, a decrease of 17.25% compared to the same period last year[3] - The net profit after deducting non-recurring gains and losses was ¥88,418,320.32, down 17.96% year-on-year[3] - The basic earnings per share for Q3 2021 was ¥0.30, a decrease of 18.08% compared to the same period last year[3] - Total operating revenue for the current period reached ¥19,350,905,221.84, an increase of 18.9% compared to ¥16,288,560,957.27 in the previous period[18] - Total operating costs amounted to ¥18,733,139,755.97, up 19.5% from ¥15,681,790,040.81 in the prior period[18] - Operating profit for the current period was ¥646,384,309.00, representing a 12.1% increase from ¥576,046,684.31 in the previous period[19] - Net profit for the current period was ¥466,993,621.42, an increase of 7.8% compared to ¥433,168,445.94 in the same period last year[19] - The company reported a basic earnings per share of ¥0.91, up from ¥0.84 in the previous period[20] - Other income increased to ¥25,286,954.89 from ¥16,174,470.91 in the previous period, reflecting a growth of 56.5%[19] Cash Flow - The operating cash flow for the year-to-date period was ¥178,741,693.17, reflecting a significant decline of 46.68%[3] - Cash flow from operating activities totaled ¥21,361,860,431.16, compared to ¥17,877,382,937.26 in the previous period[21] - Cash flow from investing activities resulted in a net outflow of ¥38,320,605.14, improving from a net outflow of ¥58,224,041.63 in the prior period[23] - Cash flow from financing activities showed a net outflow of ¥440,398,843.78, slightly worse than the net outflow of ¥421,018,996.99 in the previous period[24] Assets and Liabilities - Total assets at the end of Q3 2021 amounted to ¥14,367,033,204.67, an increase of 1.65% from the end of the previous year[3] - Current assets totaled CNY 12,815,086,837.49, compared to CNY 12,567,156,348.84 at the end of 2020, reflecting a growth of approximately 1.97%[14] - Total liabilities stood at CNY 8,821,235,830.29, slightly up from CNY 8,809,686,211.29, indicating a marginal increase[15] - The company's equity attributable to shareholders increased by 4.67% to ¥3,798,291,277.34 compared to the end of the previous year[4] - The company's equity attributable to shareholders reached CNY 3,798,291,277.34, up from CNY 3,628,935,746.35, marking an increase of about 4.67%[16] - The company reported a decrease in short-term borrowings to CNY 3,470,540,955.19 from CNY 3,558,263,244.51, a reduction of approximately 2.5%[15] Inventory and Receivables - Accounts receivable increased to CNY 8,010,878,527.55 from CNY 7,648,002,240.45, representing a growth of approximately 4.75%[14] - Inventory increased to CNY 2,107,667,945.24 from CNY 2,013,591,273.23, reflecting a growth of about 4.67%[14] Government Subsidies and Other Income - The company received government subsidies totaling ¥5,779,473.04 during the reporting period, which is part of the non-recurring gains[6] - The company reported a 56.34% increase in other income due to higher government tax refunds received[8] Compliance and Reporting - The third quarter report of Jia Shitang Pharmaceutical Co., Ltd. is unaudited[25] - The company implemented new leasing standards starting from 2021, with no adjustments made to prior comparative data[25] - The board of directors announced the financial report on October 23, 2021[25] - There are no adjustments to the financial statements related to the new leasing standards for the first year of implementation[25] - The company did not apply retrospective adjustments for prior comparative data under the new leasing standards[25] - The financial report does not include any significant user data or performance guidance[25] - There are no mentions of new product development or market expansion strategies in the report[25] - The report does not indicate any mergers or acquisitions planned by the company[25] - The company has not disclosed any new strategies in the financial report[25] - The report is focused solely on compliance with new accounting standards without detailed financial performance metrics[25]